Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2012
Loading references information
Aim of this randomized, double-blind, placebo-controlled, cross-over study is to investigate cannabinoid-induced changes in neurophysiological parameters in a group of 40 patients with secondary or primary progressive Multiple Sclerosis (MS).
Epistemonikos ID: 9caec83ea528ee7c4c807e4839743957364ea806
First added on: Mar 31, 2022